Skip to content
← Full study record

NCT02684162 · MORE INFO

Limitations, agreements, and source contact

Guadecitabine and Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapsing After Allogeneic Stem Cell Transplant · Source last updated 2025-11-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
BOran@mdanderson.org
organization
The University of Texas MD Anderson Cancer Center
phone
713-745-2820
title
Betul Oran, MD / Stem Cell Transplantation
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
BOran@mdanderson.org
organization
The University of Texas MD Anderson Cancer Center
phone
713-745-2820
title
Betul Oran, MD / Stem Cell Transplantation

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice